Dr. Tarragó has a PhD in Molecular Biology from the University of Barcelona.
She has solid expertise in drug discovery, gained during 15 years spent conducting several research lines on proteases and protease inhibitors at the Spanish National Research Council (CSIC) and IRB Barcelona.
She has experience in managing internationally-funded research projects, as well as directing joint undertakings with biotech companies. She has published over 40 papers and two books, and she holds four patents. In addition to her scientific qualifications, she holds an Executive MBA (ESADE) and has participated in entrepreneurship programmes, including “Ignite” at Cambridge Judge Business School and “BioEmprendedor XXI” (Barcelona).
Co-Founder and former CEO at Iproteos. She is Board Member at Accure Therapeutics. She is currently a Business Advisor at Caixa Impulse, as well as a mentor at EIT Health.
She has also been nominated as one of the 10 best European female entrepreneurs in the field of biotechnology in 2019 by Labiomed. She is currently co-founder and CEO at Exheus.